 |
Top 16 medical and healthcare startups in Belgium
Oct 11, 2024 | By Jason Kwon | 22 |
1
Funding: $369.7M
ITeos Therapeutics is a biotechnology company that specializes in tumor immunology, cancer immunotherapy, and drug discovery.
ITeos Therapeutics is a biotechnology company that specializes in tumor immunology, cancer immunotherapy, and drug discovery.
2
Funding: $237M
AgomAb Therapeutics is a Company is developing growth factor-mimetic agonistic monoclonal antibodies to regenerate damaged tissues.
AgomAb Therapeutics is a Company is developing growth factor-mimetic agonistic monoclonal antibodies to regenerate damaged tissues.
3
Funding: $149.1M
Promethera Biosciences is a biopharmaceutical company focused on cell therapy products to treat liver diseases.
Promethera Biosciences is a biopharmaceutical company focused on cell therapy products to treat liver diseases.
4
Funding: €68.6M
ExeVir Bio develops single-domain antibody-based therapies that help patients ward off viral infections.
ExeVir Bio develops single-domain antibody-based therapies that help patients ward off viral infections.
5
Funding: €45M
Indigo Diabetes is a medical device company that develops a multi-biomarker sensor for people with diabetes.
Indigo Diabetes is a medical device company that develops a multi-biomarker sensor for people with diabetes.
6
Funding: €29.7M
Amyl Therapeutics unique technology offers a curative solution for all forms of amyloid mediated diseases
Amyl Therapeutics unique technology offers a curative solution for all forms of amyloid mediated diseases
8
Funding: €4M
ElmediX develops a technology platform to accurately administer optimal thermal doses to boost the effectiveness of conventional pancreatic cancer treatments.
ElmediX develops a technology platform to accurately administer optimal thermal doses to boost the effectiveness of conventional pancreatic cancer treatments.
9
Funding: €3.9M
Minze Health enables better care for billion people with Lower Urinary Tract Symptoms (LUTS).
Minze Health enables better care for billion people with Lower Urinary Tract Symptoms (LUTS).
10
Funding: $3.55M
Oncurious focuses on clinical development activities in orphan pediatric oncology treatment with a focus on preclinical research and drug development programs, enabling its clients to receive new approaches for immuno-oncology drugs targeting a broad spectrum of cancers.
Oncurious focuses on clinical development activities in orphan pediatric oncology treatment with a focus on preclinical research and drug development programs, enabling its clients to receive new approaches for immuno-oncology drugs targeting a broad spectrum of cancers.
